Dianhydrogalactitol

Dianhydrogalactitol

SCHEMBL8375579

OC(C1CO1)C(O)C1CO1

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dianhydrogalactitol SCHEMBL4304284 1.00 THRB (0.30) THRBLMNA
Dianhydrogalactitol SCHEMBL15765612 1.00 THRB (0.30) THRBLMNA
Dianhydrogalactitol SCHEMBL15496475 1.00 THRB (0.30) THRBLMNA
Dianhydrogalactitol SCHEMBL17264073 1.00 THRB (0.30) THRBLMNA
Dianhydrogalactitol SCHEMBL4304281 1.00 THRB (0.30) THRBLMNA
Dianhydrogalactitol SCHEMBL21761430 1.00 THRB (0.30) THRBLMNA
Dianhydrogalactitol SCHEMBL4307933 1.00 THRB (0.30) THRBLMNA
Dianhydrogalactitol SCHEMBL16387832 1.00 THRB (0.30) THRBLMNA
Dianhydrogalactitol SCHEMBL4306431 1.00 THRB (0.30) THRBLMNA
SCHEMBL16685342 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119462682-A Diamino compound based on dianhydro iditol, PI film and preparation method thereof 江汉大学 2025-02-18 CN claimed
WO-2026085795-A1 SILENCED FC REGIONS PROTEINTECH GROUP, INC. (US) 2026-04-30 WO disclosed
US-20250205138-A1 Organic Compounds GIVAUDAN SA (CH) 2025-06-26 US disclosed
WO-2025125502-A1 COMBINED AGENTS WITH SYNERGISTIC EFFECT AGAINST GLIOMAS EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET (DE) 2025-06-19 WO disclosed
EP-4570247-A1 COMBINED AGENTS WITH SYNERGISTIC EFFECT AGAINST GLIOMAS Eberhard Karls Universität Tübingen Medizinische Fakultät (DE) 2025-06-18 EP disclosed
EP-4558542-A1 SURFACE ADDITIVE BASED ON POLYSILOXANE MODIFIED UNSATURATED POLYESTER BYK-Chemie GmbH (DE) 2025-05-28 EP disclosed
CN-119462682-A Diamino compound based on dianhydro iditol, PI film and preparation method thereof 江汉大学 2025-02-18 CN disclosed
CN-119462682-A Diamino compound based on dianhydro iditol, PI film and preparation method thereof 江汉大学 2025-02-18 CN disclosed
CN-118388752-A Novel polyesters and compositions containing same 诺瓦蒙特股份公司 2024-07-26 CN disclosed
EP-4396232-A1 ANTI-GLYCO-LAMP1 ANTIBODIES AND THEIR USES Go Therapeutics, Inc. (US) 2024-07-10 EP disclosed
US-20140066642-A1 METHOD OF SYNTHESIS OF SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL DEL MAR PHARMACEUTICALS (CA) 2014-03-06 US disclosed
US-20140066642-A1 METHOD OF SYNTHESIS OF SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL DEL MAR PHARMACEUTICALS (CA) 2014-03-06 US disclosed
US-20140017798-A1 ANALYTICAL METHODS FOR ANALYZING AND DETERMINING IMPURITIES IN DIANHYDROGALACTITOL DEL MAR PHARMACEUTICALS (CA) 2014-01-16 US disclosed
US-7531162-B2 Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2009-05-12 US disclosed
US-7531162-B2 Transcobalamin receptor binding conjugates useful for treating abnormal cellular proliferation MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2009-05-12 US disclosed
EP-1754712-A2 Transcobalamin binding conjugates useful for treating abnormal cellular proliferation MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2007-02-21 EP disclosed
US-5879852-A POLYMERIC BINDER HAVING ACID-LABILE GROUPS AGFA-GEVAERT AG (DE) 1999-03-09 US disclosed
US-5654121-A A HYDROXY- OR ESTER-CONTAINING STYRENE-BASED POLYMER HAVING ACID-LABILE GROUPS AND A PHOTOSENSITIVE COMPOUND RELEASING A STRONG ACID UPON IRRADIATION; STORAGE STABILITY; HEAT RESISTANCE; LOW DARK EROSION; PRINTING PLATES; PHOTORESISTS AGFA-GEVAERT AG (DE) 1997-08-05 US disclosed
EP-0683435-B1 Positive-working radiation-sensitive composition AGFA GEVAERT AG (DE) 1997-06-04 EP disclosed
EP-0683435-A1 Positive-working radiation-sensitive composition HOECHST AKTIENGESELLSCHAFT (DE) 1995-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140066642-A1 METHOD OF SYNTHESIS OF SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL DDOST, DAD1, KRTCAP2 THRB 1889/4885LMNA 3131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.